For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231030:nRSd7331Ra&default-theme=true
RNS Number : 7331R Versarien PLC 30 October 2023
30 October 2023
Versarien Plc
("Versarien" or the "Company")
Result of General Meeting
Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased
to confirm that at the Company's General Meeting held earlier today, all
resolutions were duly passed. Full details of the resolutions are set out in
the Notice of General Meeting dated 12 October 2023 and available on the
Company's website at:
https://www.versarien.com/investors/reports-and-presentations/
(https://www.versarien.com/investors/reports-and-presentations/)
The proxy votes cast were as follows:
Resolution For Against Abstain
1 - to sub-divide the Existing Ordinary Shares into New Ordinary Shares and 23,267,848 96.07% 951,505 3.93% 645,931
Deferred Shares
2 - to alter the Articles to allow for the issue of New Deferred Shares 23,260,834 95.77% 1,027,547 4.23% 576,903
3 - to authorise the Directors to allot shares in the Company 22,845,045 95.73% 1,019,150 4.27% 1,001,089
4 - to disapply statutory pre-emption rights 22,609,443 94.75% 1,253,097 5.25% 1,002,744
Share Capital Reorganisation
Following the passing of the resolutions at the General Meeting, each of the
Company's 330,779,690 Existing Ordinary Shares will be sub-divided into one
New Ordinary Share of 0.1p (the "New Ordinary Shares") and one deferred share
of 0.9p ("New Deferred Shares"). The New Deferred Shares will have little
economic value as they will not carry any rights to vote or dividend rights,
although the New Deferred Shares will rank pari passu with the New Ordinary
Shares on a return of capital or on a winding up of the Company.
Admission to AIM and Total Voting Rights
Dealings on AIM in the Existing Ordinary Shares is expected to cease at the
close of business on 30 October 2023. Application has been made for the
admission of 330,779,690 New Ordinary Shares to trading on AIM ("Admission")
and it is expected that Admission will take place and that trading in the New
Ordinary Shares will commence at 8.00 a.m. on or around 31 October 2023. No
application will be made for admission of the New Deferred Shares to trading
on AIM nor will any such application be made to any other exchange.
Following Admission, there will be a total of 330,779,690 New Ordinary Shares,
with voting rights, in issue. The Company does not hold any shares in
treasury. Consequently, 330,779,690 is the figure which may be used by
shareholders as the denominator for the calculation by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
Unless otherwise indicated, all defined terms in this announcement shall have
the same meaning as described in the Company's announcement dated 12 October
2023 and the Circular which was posted to shareholders on the same day.
For further information please contact:
Versarien c/o IFC
Stephen Hodge, Chief Executive Officer
Chris Leigh, Chief Financial Officer
SP Angel Corporate Finance (Nominated Adviser and Broker) +44 (0)20 3470 0470
Matthew Johnson, Adam Cowl
IFC Advisory Limited (Financial PR and Investor Relations) +44 (0) 20 3934 6630
Tim Metcalfe, Zach Cohen
For further information please see: http://www.versarien.com
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.versarien.com%2F&data=05%7C01%7Ctwhitfield%40mclnews.com%7Ca6f36820d41746bbb8f008da42f2dd6a%7C7560185ee95f4d5a8cc0c244cb450a3e%7C0%7C0%7C637895909595351380%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=vp8yFEBNrElWqj0WOIqnwLTzPx3mbDopgjGylVz4v0c%3D&reserved=0)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ROMWPGGAUUPWGGU